JPMorgan's $6 Billion Case of Lyme Disease
We've run many stories at Forbes parsing the reasons for JPMorgan's multibillion-dollar trading loss this month. As the days tick past, analysts and journalists continue to struggle to comprehend and explain the complex hedging strategy that did so much damage at the venerable bank. But on Sunday, The New York Times had a front-page piece ...
- Original article
- Login or register to post comments

